A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
作者:
主题词
吸收测定法, 光子(Absorptiometry, Photon);成年人(Adult);骨密度(Bone Density);骨密度保护剂(Bone Density Conservation Agents);氯膦酸(Clodronic Acid);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);用药计划表(Drug Administration Schedule);女(雌)性(Female);股骨颈(Femur Neck);随访研究(Follow-Up Studies);糖皮质激素类(Glucocorticoids);人类(Humans);炎性肠疾病(Inflammatory Bowel Diseases);注射, 静脉内(Injections, Intravenous);腰椎(Lumbar Vertebrae);男(雄)性(Male);中年人(Middle Aged);骨质疏松(Osteoporosis);回顾性研究(Retrospective Studies);胸椎(Thoracic Vertebrae);治疗结果(Treatment Outcome)
DOI
10.1016/j.cgh.2007.05.016
PMID
17683996
发布时间
2016-11-24
- 浏览15
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文